chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse event; A nurse gave monovalent Moderna vaccine to patient 0.25 ml instead of the 0.5 ml; This spontaneous case was reported by a nurse and describes the occurrence of WRONG PRODUCT ADMINISTERED (A nurse gave monovalent Moderna vaccine to patient 0.25 ml instead of the 0.5 ml) and NO ADVERSE EVENT (No adverse event) in an elderly patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 26-Apr-2023, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 26-Apr-2023, the patient experienced WRONG PRODUCT ADMINISTERED (A nurse gave monovalent Moderna vaccine to patient 0.25 ml instead of the 0.5 ml). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (A nurse gave monovalent Moderna vaccine to patient 0.25 ml instead of the 0.5 ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (A nurse gave monovalent Moderna vaccine to patient 0.25 ml instead of the 0.5 ml).    No concomitant information was reported. Suspect product dosage text was reported as unknown. This case is reported for patient 4 out of 6 patients. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-721461 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-721461:Patient 1
Had the shot and still got it/Suspected vaccination failure; Still got it; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 01-Oct-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient agreed and stated that had the shot and still got them. The patient mentioned that no more fake, money making shots for him/her. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
rainbow color; Swelling at the injection site; Bruising at the injection site; Size of an orange; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (rainbow color), INJECTION SITE SWELLING (Swelling at the injection site), INJECTION SITE BRUISING (Bruising at the injection site) and CONDITION AGGRAVATED (Size of an orange) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced SKIN DISCOLOURATION (rainbow color), INJECTION SITE SWELLING (Swelling at the injection site), INJECTION SITE BRUISING (Bruising at the injection site) and CONDITION AGGRAVATED (Size of an orange). At the time of the report, SKIN DISCOLOURATION (rainbow color), INJECTION SITE SWELLING (Swelling at the injection site), INJECTION SITE BRUISING (Bruising at the injection site) and CONDITION AGGRAVATED (Size of an orange) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
heart attack; couldn't take a breath/she couldn't breathe; passed out a few times; couldn't walk or make use of her legs; got so cold; This is a spontaneous report from a contactable consumer (patient).    A 33-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 18Jun2021 08:00 (Batch/Lot number was not reported) at the age of 33-year-old as single dose for covid-19 immunization. The patient's medical history was none, no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on 28May2021 08:00 AM at the age of 33-year-old, administered in Right arm for covid-19 immunization. On 10Aug2021, she woke up at 2 am and felt like she was having a heart attack; she couldn't take a breath/she couldn't breathe, and she passed out a few times. She also couldn't walk or make use of her legs so her husband had to carry her around. Her breathing eventually returned but she was not breathing properly for the next few minutes that followed. After a while, she got so cold like she was stuck in a deep freezer and nothing was successful in warming her up. This episode lasted for about an hour before it passed. She asked her husband to hold off on calling the ambulance because she knew they could not afford the cost but she scheduled a full physical with her doctor the next day because she knew something was very wrong. The events resulted in [Doctor or other healthcare professional office/clinic visit, Life threatening illness (immediate risk of death from the event)]. No treatment received for the events. The outcome of the events was recovered on an unspecified date. No covid prior vaccination, no covid tested post vaccination. The lot number for bnt162b2 was not provided and will be requested during follow up.
the patient received improperly stored vaccine at an unspecified date; This spontaneous report as received from a physician refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On an unknown date, the patient was vaccinated with improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) one dose (exact dose, site and route of administration were not reported) lot # S007075, exipration number 06-SEP-2020 for prophylaxis. The outcome of the event was unknown. Administered dose of vaccine experienced the temperature excursion at 32.5 degrees Fahrenheit for 8 hours. Data logger was involved. There were no previous excursions reported.
Felt tingling sensation in arm. Arm was weak a day after flu shot. 2 weeks later her arm is still feeling weak.
Information has been received from a physician concerning his father who on an unknown date, was vaccinated with ZOSTAVAX (Oka/Merck) (lot # not reported).  Subsequently the patient experienced swollen lymph nodes all over his body.  The fluid was removed from biopsy (result not reported).  Unspecified medical attention was sought.  Additional information has been requested.
dose given after expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose given after expiration date) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 002C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Jul-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (dose given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.
While the vaccinator was injecting the client with his 2nd moderna vaccine, some of the vaccine leaked from the junction between the needle and the syringe. The client did not receive the entire dose. Client was made aware of the incident.
pt states he told them he was on blood thinner so they had him stay 30 minutes before leaving after taking the vax.  At this time he became nauseated.  He went home and  laid down and fell asleep.  When he woke up he called his PCP because he wasn't feeling well.  His heart rate was running from 80-90 and fluctuating like he was about to have a heart attack. He was told to call back if he wasn't feeling better.  On 4/9  his heart  was running about 90-115.  On 4/10 his heart was running from 139-142.  He called his doctors office and they told him to go to the ER.  He went to hospital.   He was given heart  EKG, labs  and IV.  He was given aspirin.  His INR was at 2.  His heart rate came down to 115.   His blood was low.  His DX was Sinus Tachycardia.  He was admitted to the Heart Floor.  He was treated for 2 days and released.  They told him they thought he was reacting to taking the vaccination and to FU w/ PCP.  He said his heart rate is fluctuating  and is currently at 101.  He doesn't see a Cardiologist since he cannot have open heart surgery due to his underlying health conditions.
Onset of symptoms 5 hours following injection and worsened over 24 hours; low-grade fever, body aches, nausea, diarrhea, fatigue, headache, swollen/painful underarm on injection arm. While most symptoms cleared after 36 hours, underarm swelling/pain and fatigue persist.
Pediatric dose was given to adults mistakenly; Moderna COVID-19 vaccine administered to patients post temperature excursion; Poor quality vaccine administered; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Poor quality vaccine administered).    Concomitant product use was not provided by the reporter.  It was reported there was a temperature excursion between 26-May-2022 to 30-Sep-2022 and lot AR5186C was affected between 08-Sep-2022 to 27-Sep-2022. AR5186C was previously reported. Pediatric dose was given to adults mistakenly and were reported to CDPH, VAERS, CAIR and each patient that received the error dose, with instructions to re-vaccinate 2 months from the initial error dose. 051B22A was kept in the freezer upon receipt of shipment on 08-Jan-2022 and individual vials were put in the refrigerator on the day of use.  No treatment information was provided.  This case contains information for the 57 of 104 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-669791 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-669791:master case
Around 2:00 AM I started getting chills and shaking, also was nauseous  with headache.
The left side of my face, ear, throat and teeth hurt; The left side of my face, ear, throat and teeth hurt; pain in neck; pain in left shoulder; The shortness of breath lasted over; My lips were tingly; I could feel the end of my nose. My throat was closing/throat closing a little bit; I had pain in my arm; my muscles ached.; The left side of my face, ear, throat and teeth hurt; The left side of my face, ear, throat and teeth hurt; anaphylaxis; allergic reaction to the first dose of the Pfizer COVID 19 vaccine; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number: EN5318), via an unspecified route of administration on 22Jan2021 at 10:30 at single dose in left arm for covid-19 immunization. Medical history included drug allergies from an unknown date. There were no concomitant medications. The patient experienced anaphylaxis on an unspecified date in 2021. The patient had a little bit of an allergic reaction to the first dose of the Pfizer COVID 19 vaccine in 2021, it was not severe enough to use an Epipen. The shortness of breath from 22Jan2021 18:00 lasted over a week. Her lips were tingly from 22Jan2021 14:30, she could feel the end of her nose. Her throat was closing from 22Jan2021 14:30. She had pain in her arm from 22Jan2021 11:00, and her muscles ached from an unspecified date in 2021, the left side of her face, ear, throat and teeth hurt (facial pain from an unspecified date in 2021, ear pain from 22Jan2021 23:00, throat pain from an unspecified date in 2021, tooth pain from 22Jan2021 23:00), pain in left shoulder from 22Jan2021 20:30, pain in neck from 22Jan2021 23:00. She did have to take Benadryl for treatment of shortness of breath. She felt better after 1.5 weeks. The outcome of events anaphylaxis, allergic reaction, muscles ached, Facial pain, Throat pain was unknown, outcome of event pain in arm was resolving, outcome of event tooth pain was resolved on 23Jan2021, outcome of shortness of breath was resolved on 01Feb2021, outcome of other events was resolved on 24Jan2021.
Flu like symptoms; Soreness of injection arm; Tingling sensation on face; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Soreness of injection arm), PARAESTHESIA (Tingling sensation on face) and CHILLS (Chills) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Soreness of injection arm), PARAESTHESIA (Tingling sensation on face) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN IN EXTREMITY (Soreness of injection arm), PARAESTHESIA (Tingling sensation on face) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Feb-2021: Follow-up received on 08Feb2021: no new information On 21-Apr-2021: Follow-up received on 21Apr2021: Reporter Email ID added
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 25-NOV-2013, the patient was inadvertently vaccinated with a dose of ROTATEQ, lot # H010688, expiration date 28-OCT-2013, 2 ml, oral. No adverse effects were reported. Additional information has been requested.
Patient was given a Pneumococcal 23 and should have been given Prevnar 13.  At this time, the patient's mom has not reported any problems.
Initial report received from a health care professional on 16 Aug 2010: This patient was vaccinated with MENVEO (batch number: unknown), intramuscularly on an unspecified date. The reporter stated that the patient received only liquid portion of the MENVEO. No associated illness occurred. CDC advised to repeat both vaccinations with complete product. The outcome of the event was not reported. Follow-up report received on 19 Aug 2010: The patient's demographics, treating physician's information and vaccine lot number (090701) were provided.
11/17/21 presents to ED for "cough, dyspnea, vomiting, diarrhea". PMHx "CKD not on HD, HTN, HLD"
Exhaustion; trouble breathing; Her pain as a burning sensation when she breathes; Her pain as a burning sensation when she breathes; Her condition is continually becoming worse; It takes all of her effort to get out of bed; Chest felt heavy; maybe a sinus infection; This is a spontaneous report from a contactable consumer or other non-HCP. A female patient of an unspecified age received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 01Apr2021 as single dose for covid-19 immunization. Medical history included fibromyalgia, rheumatoid arthritis. The patient's concomitant medications were not reported. On Apr2021 the patient experienced exhaustion, trouble breathing, her pain as a burning sensation when she breathes, her pain as a burning sensation when she breathes, her condition is continually becoming worse, it takes all of her effort to get out of bed. Upon follow-up received on 22Apr2021, the patient experienced chest felt heavy, maybe a sinus infection on Apr2021. The patient underwent lab tests and procedures which included swab test: Negative on Apr2021, blood test: normal on Apr2021, electrocardiogram: normal on Apr2021, sars-cov-2 test: negative on Apr2021, sars-cov-2 test: negative on Apr2021, x-ray: normal on Apr2021 , which Can't find anything. The outcome of events was unknown.  Follow-up (22Apr2021): New Information received from the contactable consumer includes updated events and dates, of lab data and questions regarding events.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Client received Pfizer vaccines for Covid on * March 7 and April 7, 2021.    *Client not sure of exact first dose date but states it was about a month prior to 2nd dose and she is sure about date of second dose.  Developed Covid symptoms on 9/16: fever, headache, fatigue.  Reported as a case of breakthrough Covid in a previously vaccinated person.  Client received treatment of antibody infusion on 9/22/2021.
This is a spontaneous report from a contactable Physician via Pfizer sales representative. A patient of unspecified age ethnicity and gender received TRUMENBA lot: M15167, via an unspecified route of administration on 26Sep2016 at 0.5 ml, single for immunisation.  The patient medical history and concomitant medications were not reported.  The patient experienced hives on 28Sep2016 with outcome of unknown, itching warm and 'bigger the pm' on an unspecified date with outcome of unknown. There were no difficulty breathing, no other systemic symptoms, Treatment includes BENADRYL by mouth as needed, hydrocortisone 1% twice a day as needed and warm compresses.
Pain in right side neck; Swelling on right arm; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain in right side neck), PERIPHERAL SWELLING (Swelling on right arm) and VACCINATION SITE PAIN (Vaccination site pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure management.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced NECK PAIN (Pain in right side neck), PERIPHERAL SWELLING (Swelling on right arm) and VACCINATION SITE PAIN (Vaccination site pain). At the time of the report, NECK PAIN (Pain in right side neck), PERIPHERAL SWELLING (Swelling on right arm) and VACCINATION SITE PAIN (Vaccination site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       concomitant medication included blood pressure pill.  Treatment medication included Tylenol.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: TCR attached 12 MAY 2021 and its NNI.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
received two doses of Pfizer's and yesterday received Moderna vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (received two doses of Pfizer's and yesterday received Moderna vaccine) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (received two doses of Pfizer's and yesterday received Moderna vaccine). On 04-Aug-2021, INTERCHANGE OF VACCINE PRODUCTS (received two doses of Pfizer's and yesterday received Moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product information was not provided. Treatment information was not provided.
1 day after influenza vaccination, he had extreme soreness to his upper arm and stiffness. He claims he had limited range of motion which has mostly resolved at this time, stating "I have 80-90% use back".